Annual EBITDA
-$12.02 M
+$4.37 M+26.66%
December 1, 2023
Summary
- As of February 7, 2025, NLSP annual EBITDA is -$12.02 million, with the most recent change of +$4.37 million (+26.66%) on December 1, 2023.
- During the last 3 years, NLSP annual EBITDA has fallen by -$9.39 million (-357.26%).
- NLSP annual EBITDA is now -357.26% below its all-time high of -$2.63 million, reached on December 31, 2020.
Performance
NLSP EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NLSP EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +26.7% | - | - |
3 y3 years | -357.3% | - | - |
5 y5 years | -195.8% | - | - |
NLSP EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -1.2% | +26.7% | ||||
5 y | 5-year | -357.3% | +26.7% | ||||
alltime | all time | -357.3% | +26.7% |
NLS Pharmaceutics AG EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2023 | -$12.02 M(-26.7%) | - | - |
Dec 2022 | -$16.38 M(+38.0%) | - | - |
Dec 2021 | -$11.87 M(+351.6%) | - | - |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2020 | -$2.63 M(-43.2%) | - | - |
Dec 2019 | -$4.63 M(+13.9%) | - | - |
Dec 2018 | -$4.06 M(-29.6%) | - | - |
Dec 2017 | -$5.77 M | - | - |
FAQ
- What is NLS Pharmaceutics AG annual EBITDA?
- What is the all time high annual EBITDA for NLS Pharmaceutics AG?
- What is NLS Pharmaceutics AG annual EBITDA year-on-year change?
What is NLS Pharmaceutics AG annual EBITDA?
The current annual EBITDA of NLSP is -$12.02 M
What is the all time high annual EBITDA for NLS Pharmaceutics AG?
NLS Pharmaceutics AG all-time high annual EBITDA is -$2.63 M
What is NLS Pharmaceutics AG annual EBITDA year-on-year change?
Over the past year, NLSP annual EBITDA has changed by +$4.37 M (+26.66%)